No buy transactions available for this period
Enavate Sciences Gp, LLC filed its 13F report for Q1 2026 on May 15, 2026. The portfolio totaled 351.51 M reflecting a -30.64% change from the prior quarter, spanning 7 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. No significant position changes were reported during the quarter.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Enavate Sciences Gp submitted their Form 13F-HR for the Q1 2026 period on 05/15/2026. This was the only submission for the quarter.
In the Q1 2026 filing, Enavate Sciences Gp reported a managed portfolio value of 351.51 M, consisting of 7 individual positions.
This page displays the raw filing documents. To see which stocks Enavate Sciences Gp bought or sold during Q1 2026, please visit Enavate Sciences Gp's Portfolio Analysis page.